Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro J. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. https://www.ajmc.com/view/dec04-1992ps451-s461

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro J
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The risk of stroke attributable to atrial fibrillation by age
    The risk of stroke attributable to atrial fibrillation increases from 1.5% for those ages 50 to 59 to 23.5% for those ages 80 to 89.  
  • AFib patients over age 80, 2050
    By 2050, it is estimated that more than 50% of Americans with atrial fibrillation will be age 80 and older.  
  • Atrial fibrillation prevalence, 2012
    Atrial fibrillation is estimated to impact between 2.7 and 6.1 million Americans.  
  • Hospitalization costs for patients with nonrecurrent ischemic stroke
    The cost of hospitalization for patients with nonrecurrent ischemic stroke is $4,991 more in patients with atrial fibrillation, than in patients without the disease.        
  • Median age AFib patient
    The median age of people with atrial fibrillation is about 75 years.